![Christopher Gerry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Gerry
Algemeen Adviseur bij
FAETH THERAPEUTICS, INC.
Vermogen: 25 960 $ op 31-07-2026
Profiel
Christopher W.
Gerry is currently Secretary & General Counsel at Faeth Therapeutics, Inc., a position starting in 2026.
Formerly, Mr. Gerry was Vice President & Deputy General Counsel at AVROBIO, Inc. from 2021 to 2022 and an Associate at Cooley LLP from 2013 to 2019.
Education includes undergraduate studies at Dickinson College and graduate studies at Boston University School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-06-2026 | 953 ( 0% ) | 25 960 $ | 31-07-2026 |
Actieve functies van Christopher Gerry
| Bedrijven | Functie | Begin |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Algemeen Adviseur | 01-07-2022 |
Eerdere bekende functies van Christopher Gerry
| Bedrijven | Functie | Einde |
|---|---|---|
| TECTONIC THERAPEUTIC, INC. | Corporate Officer/Principal | 01-07-2022 |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01-10-2019 |
Opleiding van Christopher Gerry
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
67
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Dickinson College
 Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cooley LLP
Cooley LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Boston University School of Law
 Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
